Table 5.
SNP | Test allele | Phenotype | Unit | HYPEST | CADCZ | EGCUT | Meta-analysisa | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
β (SE) [95 % CI] |
P value | β (SE) [95 % CI] |
P value | β (SE) [95 % CI] |
P value | β (SE) [95 % CI] |
P value | ||||
rs8060301 | A | HDL | mmol/L |
0.06 (0.04) [−0.15, 0.03] |
1.77 × 10−1 |
0.09 (0.04) [0.01, 0.16] |
2.54 × 10−2 |
0.07 (0.04) [−0.01, 0.15] |
5.82 × 10−2 |
0.07 (0.02) [0.03, 0.12] |
1.25 × 10−3 |
DBP | mmHg |
0.60 (1.65) [−3.84, 2.64] |
7.17 × 10−1 |
−3.45 (1.29) [−6.00, −0.92] |
8.34 × 10−3 |
−2.31 (1.10) [−4.47, −0.14] |
3.69 × 10−2 |
−2.10 (0.75) [−3.56, −0.63] |
4.97 × 10−3 | ||
SBP | mmHg |
−1.18 (2.52) [−3.75, 6.12] |
6.39 × 10−1 |
−3.87 (2.17) [−8.12, 0.37] |
7.58 × 10−2 |
−1.71 (1.60) [−4.86, 1.45] |
2.87 × 10−1 |
−2.20 (1.15) [−4.45, 0.04] |
5.43 × 10−2 | ||
rs12444338 | T | HDL | mmol/L |
0.04 (0.04) [−0.13, 0.05] |
3.67 × 10−1 |
0.09 (0.04) [0.02, 0.16] |
1.44 × 10−2 |
0.08 (0.04) [0.00, 0.15] |
4.99 × 10−2 |
0.07 (0.02) [0.03, 0.12] |
1.51 × 10−3 |
rs62040565 | C | HDL | mmol/L |
0.06 (0.04) [−0.14, 0.02] |
1.41 × 10−1 |
0.07 (0.04) [−0.01, 0.14] |
8.88 × 10−2 |
0.03 (0.05) [−0.06, 0.12] |
5.10 × 10−1 |
0.06 (0.02) [0.01, 0.10] |
2.36 × 10−2 |
rs12443878 | A | HDL | mmol/L |
0.06 (0.04) [−0.14, 0.03] |
1.94 × 10−1 |
0.05 (0.04) [−0.03, 0.12] |
2.24 × 10−1 |
0.03 (0.04) [−0.05, 0.11] |
4.13 × 10−1 |
0.04 (0.02) [−0.01, 0.09] |
5.48 × 10−2 |
SE standard error, CI confidence
aOnly associations, which demonstrated enhanced significance in meta-analysis compared to all sample-specific tests, are given. Effects and P values are calculated using linear regression, including age and gender as covariates in the model; results were combined using the inverse-variance method under a fixed-effects model. Estimated significance threshold after correction for multiple testing P < 8.33 × 10−4